Chemical derivatives and their use as anti-telomerase agent

Details for Australian Patent Application No. 2002251140 (hide)

Owner Aventis Pharma S.A.

Inventors Laoui, Abdelazize; Doerflinger, Gilles; Caulfield, Thomas; Mailliet, Patrick; Hamy, Francois; Riou, Jean-Francois; Mergny, Jean-Louis

Agent Watermark

Pub. Number AU-B-2002251140

PCT Pub. Number WO2002/076975

Priority 01/10370 02.08.01 FR; 01/03916 23.03.01 FR

Filing date 22 March 2002

Wipo publication date 8 October 2002

Acceptance publication date 15 March 2007

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/5377 (2006.01)

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

Event Publications

27 March 2003 Application Open to Public Inspection

  Published as AU-B-2002251140

15 March 2007 Application Accepted

  Published as AU-B-2002251140

12 July 2007 Standard Patent Sealed

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002251141-METHOD FOR DATA TRANSMISSION BY A MOBILE STATION COMPRISING A MAXIMUM DATAGRAM SIZE (MDS) DETERMINATION

2002251139-POLYPEPTIDES DERIVED FROM RNA POLYMERASES AND USE THEREOF